Format

Send to:

Choose Destination
See comment in PubMed Commons below
Trends Pharmacol Sci. 2010 May;31(5):199-205. doi: 10.1016/j.tips.2010.01.003. Epub 2010 Feb 19.

Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.

Author information

  • 1Department of NanoMedicine and Biomedical Engineering, The University of Texas Health Science Center at Houston,1825 Pressler, Suite 537, Houston, TX 77030, USA.

Abstract

Nanomedicine is an emerging field that utilizes nanotechnology concepts for advanced therapy and diagnostics. This convergent discipline merges research areas such as chemistry, biology, physics, mathematics and engineering. It therefore bridges the gap between molecular and cellular interactions, and has the potential to revolutionize medicine. This review presents recent developments in nanomedicine research poised to have an important impact on the treatment of cardiovascular disease. This will occur through improvement of the diagnosis and therapy of cardiovascular disorders as atherosclerosis, restenosis and myocardial infarction. Specifically, we discuss the use of nanoparticles for molecular imaging and advanced therapeutics, specially designed drug eluting stents and in vivo/ex vivo early detection techniques.

Published by Elsevier Ltd.

PMID:
20172613
[PubMed - indexed for MEDLINE]
PMCID:
PMC2862836
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk